4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline

C32H28ClN5 — CID 40916471

IUPAC4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline
SMILESCc1ccc(C2=NN(c3nc(-c4ccccc4)c4cc(Cl)ccc4n3)[C@@H](c3ccc(N(C)C)cc3)C2)cc1
InChIInChI=1S/C32H28ClN5/c1-21-9-11-22(12-10-21)29-20-30(23-13-16-26(17-14-23)37(2)3)38(36-29)32-34-28-18-15-25(33)19-27(28)31(35-32)24-7-5-4-6-8-24/h4-19,30H,20H2,1-3H3/t30-/m1/s1
InChIKeyRWSBMTJNRSBJJO-SSEXGKCCSA-N
MW518.06 g/mol
LogP7.68
Rot. Bonds5

About 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline

4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline (PubChem CID 40916471) has the molecular formula C32H28ClN5 and a molecular weight of 518.06 g/mol. Its IUPAC name is 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline.

Molecular Properties

Compound Name4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline
PubChem CID40916471
Molecular FormulaC32H28ClN5
Molecular Weight518.06 g/mol
Exact Mass517.20
IUPAC Name4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline
SMILESCc1ccc(C2=NN(c3nc(-c4ccccc4)c4cc(Cl)ccc4n3)[C@@H](c3ccc(N(C)C)cc3)C2)cc1
InChIInChI=1S/C32H28ClN5/c1-21-9-11-22(12-10-21)29-20-30(23-13-16-26(17-14-23)37(2)3)38(36-29)32-34-28-18-15-25(33)19-27(28)31(35-32)24-7-5-4-6-8-24/h4-19,30H,20H2,1-3H3/t30-/m1/s1
InChIKeyRWSBMTJNRSBJJO-SSEXGKCCSA-N
XLogP7.68
TPSA44.62 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms38
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500518.06
LogP ≤ 57.68
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}

Analyze 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline?
The IUPAC name of 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline (CID 40916471) is 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline.
What is the SMILES notation for 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline?
The canonical SMILES for 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline is Cc1ccc(C2=NN(c3nc(-c4ccccc4)c4cc(Cl)ccc4n3)[C@@H](c3ccc(N(C)C)cc3)C2)cc1.
What is the InChIKey of 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline?
The InChIKey is RWSBMTJNRSBJJO-SSEXGKCCSA-N. The full InChI is InChI=1S/C32H28ClN5/c1-21-9-11-22(12-10-21)29-20-30(23-13-16-26(17-14-23)37(2)3)38(36-29)32-34-28-18-15-25(33)19-27(28)31(35-32)24-7-5-4-6-8-24/h4-19,30H,20H2,1-3H3/t30-/m1/s1.
What are the key properties of 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline?
4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline has a molecular weight of 518.06 g/mol, XLogP of 7.68, 5 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(3R)-2-(6-chloro-4-phenylquinazolin-2-yl)-5-(4-methylphenyl)-3,4-dihydropyrazol-3-yl]-N,N-dimethylaniline is sourced from PubChem (CID 40916471), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).